Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
Login
Register
Reset Password
Cart
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Home
Journals
Acta Pharmaceutica
Volume 67 (2017): Issue 1 (March 2017)
Open Access
Hydrazinyldiene-chroman-2,4-diones in inducing growth arrest and apoptosis in breast cancer cells: Synergism with doxorubicin and correlation with physicochemical properties
Lulzime Ballazhi
Lulzime Ballazhi
,
Faik Imeri
Faik Imeri
,
Ahmed Jashari
Ahmed Jashari
,
Emil Popovski
Emil Popovski
,
Goran Stojković
Goran Stojković
,
Aleksandar J. Dimovski
Aleksandar J. Dimovski
,
Bozhana Mikhova
Bozhana Mikhova
and
Kristina Mladenovska
Kristina Mladenovska
| Feb 21, 2017
Acta Pharmaceutica
Volume 67 (2017): Issue 1 (March 2017)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Original research paper
Published Online:
Feb 21, 2017
Page range:
35 - 52
Accepted:
Sep 21, 2016
DOI:
https://doi.org/10.1515/acph-2017-0006
Keywords
hydrazinyldiene chroman 2,4 diones
,
physicochemical properties
,
doxorubicin
,
cytotoxicity
,
breast cancer cells
© by Kristina Mladenovska
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.